Rank,Term,P-value,Z-score,Combined Score,Genes,Adjusted P-value,Gene_set,AD_genes,T2D_genes,Shared_genes,N_AD,N_T2D,N_Shared
1,PD-1 signaling,4.855615043984755e-11,129.28864864864866,3070.3856465882127,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,1.0002566990608596e-08,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,6,6,6
1,Generation Of Second Messenger Molecules R-HSA-202433,5.966687389170186e-11,124.3097713097713,2926.5309833866436,PLCG2;HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,1.1575373534990161e-08,Reactome_2022,PLCG2;HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,6,5,5
2,Generation of second messenger molecules,1.274396005202308e-10,107.71351351351352,2454.077757096895,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,1.3126278853583772e-08,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,6,6,6
2,Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,2.1922037295036425e-10,218.6951754385965,4863.987067526058,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,2.1264376176185333e-08,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
4,PD-1 Signaling R-HSA-389948,7.163593588537716e-10,163.98848684210526,3453.0791943197,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,3.474342890440792e-08,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
3,Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,5.466603686148285e-10,174.9298245614035,3730.7622006662746,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,3.474342890440792e-08,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
3,Asthma,4.945864057514308e-09,104.90526315789474,2006.2831710991154,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,3.396159986159825e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
4,Costimulation by the CD28 family,9.655091471878239e-09,48.87223587223587,901.975255215332,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,4.972372108017292e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
1,Asthma,5.887671657247697e-09,100.86538461538461,1911.4399113151069,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5.946548373820174e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
5,Allograft rejection,1.4961780385948585e-08,81.92845394736842,1476.1677825652787,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,6.164253519010818e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
2,Allograft rejection,1.7201474354166096e-08,79.44178628389155,1420.2817631362598,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.263836188442116e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
3,Graft-versus-host disease,2.8968290670549333e-08,70.83926031294452,1229.5615771136167,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.263836188442116e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
4,Type I diabetes mellitus,3.272806411264204e-08,68.97160664819944,1188.7279095659992,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.263836188442116e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
6,Graft-versus-host disease,2.5560108199449247e-08,72.81067251461988,1272.8931399153726,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.775637148477575e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
7,Type 1 diabetes mellitus,3.272806411264204e-08,68.97160664819944,1188.7279095659992,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,9.631401724577514e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
5,Intestinal immune network for IgA production,5.775888887602694e-08,60.936352509179926,1015.6254913443141,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.1667295552957442e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
9,Interferon-gamma signaling pathway,5.8689953518651786e-08,35.4012474012474,589.4660739870154,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,1.3433478249824743e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
8,Intestinal immune network for IgA production,5.775888887602694e-08,60.936352509179926,1015.6254913443141,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.3433478249824743e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
6,Autoimmune thyroid disease,9.603605500319612e-08,54.57510964912281,881.8542092262969,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.6166069258871346e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
10,MHC class II antigen presentation,8.411639128182119e-08,33.20144887155197,540.8869412974382,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,1.6314051217304429e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
11,Autoimmune thyroid disease,8.711386572347025e-08,55.73908174692049,906.0972871573292,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.6314051217304429e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
7,Viral myocarditis,1.8075876552190023e-07,47.61244019138756,739.2356258202076,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,2.608090759673132e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
8,Epstein-Barr virus infection,2.287793210359463e-07,19.705698005698007,301.31013224526566,CCND2;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,2.888338928078822e-06,KEGG_2021_Human,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CCND2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,6,5
9,Inflammatory bowel disease,2.712201977434652e-07,43.63377192982456,659.7572405235024,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,3.0436933302322204e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
10,Human T-cell leukemia virus 1 infection,3.953328439571179e-07,18.10993186582809,267.00446472841764,CDKN2B;CCND2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,3.992861723966891e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;CCND2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,7,5
11,Leishmaniasis,6.365513088486486e-07,36.33954678362573,518.4636113529241,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5.715542670762337e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
12,Antigen processing and presentation,6.790743767242382e-07,35.83994232155732,509.0180415551385,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5.715542670762337e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
12,Cell adhesion molecules (CAMs),3.845959671900612e-07,25.320280910832093,374.0077047902264,HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6.602230770096051e-06,BioPlanet_2019,HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,5,5
5,TCR Signaling R-HSA-202403,1.709911719813988e-07,29.25847665847666,455.89545715644977,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6.634457472878273e-06,Reactome_2022,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,5,5
13,Viral myocarditis,4.2347642547259884e-07,39.65510366826156,581.9294459649357,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6.685568326237096e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
14,Leishmaniasis,4.5435901246271527e-07,39.06127258444619,570.465596822135,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6.685568326237096e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
6,Costimulation By CD28 Family R-HSA-388841,3.4066251274515213e-07,41.54970760233918,618.7737664421848,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.101475457875992e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
15,Antigen processing and presentation,8.202559686212266e-07,34.420013850415515,482.35000604854355,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.126484863573151e-05,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
13,Th1 and Th2 cell differentiation,1.5471774043852934e-06,30.051421657592257,402.0603238806459,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.1777303678164903e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
14,Rheumatoid arthritis,1.6324975395476103e-06,29.708433014354068,395.87673792918434,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.1777303678164903e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
15,Staphylococcus aureus infection,1.8142442837640376e-06,29.045321637426902,383.9745498021045,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.2215911510677854e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
16,Hematopoietic cell lineage,2.2254023151187074e-06,27.803751399776036,361.88175164987877,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.404785211418684e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
17,Th17 cell differentiation,3.2660834680045093e-06,25.612745098039216,323.53812162785135,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.9404378251085614e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
16,Interferon signaling,1.5137657299829793e-06,19.814814814814813,265.5365529867323,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,1.9489733773530858e-05,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
18,Toxoplasmosis,4.08904965763566e-06,24.40973930152484,302.85646797003545,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,2.2944111967844538e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
7,Interferon Gamma Signaling R-HSA-877300,1.312104938213511e-06,31.12938596491228,421.61260221373493,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,3.636405114477445e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
8,Downstream TCR Signaling R-HSA-202424,1.7214821568988422e-06,29.373151981076287,389.85001699031733,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,4.174594230479692e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
19,Systemic lupus erythematosus,1.0189508024890478e-05,20.067813765182187,230.66250156581063,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5.4165279500733593e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
9,MHC Class II Antigen Presentation R-HSA-2132295,2.8387913965025493e-06,26.392876129718235,337.09330203716877,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6.119172565794384e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
20,Cell adhesion molecules,1.5912500595450613e-05,18.231505336768496,201.4290648690376,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,8.03581280070256e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
21,Phagosome,1.8100250203065734e-05,17.73182957393484,193.62421662814722,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,8.705358430998281e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
17,Systemic lupus erythematosus,1.1742310719056372e-05,19.464846818538884,220.97101291879463,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.00014228917694856545,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
22,Influenza A,3.278979798381879e-05,15.592499212102112,160.9986842135293,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.00015053498165298624,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
23,Tuberculosis,4.074730373780997e-05,14.873684210526315,150.3449980262844,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0001789338120660351,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
18,Phagosome,1.927849577029726e-05,17.492052278346875,189.9028205092695,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0002206316738156242,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
19,"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",2.8156875669944853e-05,11.649043203787729,122.05540109905262,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0003052798098951916,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
20,Adaptive immune system,3.854486618911474e-05,7.399522216913521,75.20643249505487,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0003970121217478819,BioPlanet_2019,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,6,6
21,Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs),0.0001253885401588909,162.20325203252034,1457.2491531056257,IGF2BP3;IGF2BP2,0.001123045185770936,BioPlanet_2019,,IGF2BP3;IGF2BP2,,0,2,0
22,Bystander B cell activation,0.0001253885401588909,162.20325203252034,1457.2491531056257,HLA-DRA;HLA-DRB1,0.001123045185770936,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
23,Eosinophils in the chemokine network of allergy,0.0001253885401588909,162.20325203252034,1457.2491531056257,HLA-DRA;HLA-DRB1,0.001123045185770936,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
10,Interferon Signaling R-HSA-913531,6.723327393029232e-05,13.334682860998651,128.110862510313,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.001304325514247671,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
11,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) Bind RNA R-HSA-428359,9.416979940433038e-05,194.65365853658537,1804.5194228526939,IGF2BP3;IGF2BP2,0.0016608128258581904,Reactome_2022,,IGF2BP3;IGF2BP2,,0,2,0
24,B lymphocyte cell surface molecules,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DRA;HLA-DRB1,0.002105428589376037,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
12,Cyclin D Associated Events In G1 R-HSA-69231,0.00014051583727508416,33.94261363636364,301.0774440913921,CDKN1C;CDKN2B;CCND2,0.0021734899560716197,Reactome_2022,,CDKN1C;CDKN2B;CCND2,,0,3,0
13,Adaptive Immune System R-HSA-1280218,0.0001456462341697477,6.063290640394088,53.56510998013485,PLCG2;HLA-DRA;TREM2;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.0021734899560716197,Reactome_2022,PLCG2;HLA-DRA;TREM2;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,8,6,6
25,Lck and Fyn tyrosine kinases in initiation of T cell receptor activation,0.00034692141370239296,88.45232815964523,704.6477129931925,HLA-DRA;HLA-DRB1,0.002858632448907718,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
26,G1 to S cell cycle control,0.00040289798305519274,23.312109375,182.22672999558148,CDKN1C;CDKN2B;CCND2,0.003192191711898835,BioPlanet_2019,,CDKN1C;CDKN2B;CCND2,,0,3,0
27,Inhibition of T cell receptor signaling by activated Csk,0.0007543579072186544,57.21664275466284,411.3672708004445,HLA-DRA;HLA-DRB1,0.005755471440260844,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
28,T cell activation co-stimulatory signal,0.0009238809256518343,51.18870346598203,357.6517529213759,HLA-DRA;HLA-DRB1,0.006797123953009924,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
30,Th1/Th2 differentiation pathway,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRA;HLA-DRB1,0.0075814005797255075,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
29,Cyclins and cell cycle regulation,0.0011100252238666322,46.3089430894309,315.0569917577159,CDKN2B;CCND2,0.0075814005797255075,BioPlanet_2019,,CDKN2B;CCND2,,0,2,0
31,Immune system,0.001140890378502382,4.379105339105339,29.672582565738555,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0075814005797255075,BioPlanet_2019,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,6,6
14,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.0006015962324961352,64.85203252032521,480.9377475175773,CDKN1C;CCND2,0.008336404936017875,Reactome_2022,,CDKN1C;CCND2,,0,2,0
15,Amyloid Fiber Formation R-HSA-977225,0.0006532602581931894,19.61940789473684,143.87961350157394,TSPAN15;APH1B;APOE,0.008448832672631917,Reactome_2022,APH1B;APOE,TSPAN15,,2,1,0
24,Cell cycle,0.002395537611775861,12.29504132231405,74.19009409618413,CDKN1C;CDKN2B;CCND2,0.010081220782890081,KEGG_2021_Human,,CDKN1C;CDKN2B;CCND2,,0,3,0
33,Cytokines and inflammatory response,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRA;HLA-DRB1,0.016031794629593324,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
32,MEF2D role in T cell apoptosis,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRA;HLA-DRB1,0.016031794629593324,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
25,Herpes simplex virus 1 infection,0.004140547981131802,5.194832924095228,28.503669745019156,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.01672781384377248,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
34,Cyclin D-associated events in G1,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN2B;CCND2,0.01830973571632348,BioPlanet_2019,,CDKN2B;CCND2,,0,2,0
16,DAP12 Signaling R-HSA-2424491,0.001647192500753881,37.39399624765478,239.64626637110106,PLCG2;TREM2,0.01997220907164081,Reactome_2022,PLCG2;TREM2,,,2,0,0
26,Vibrio cholerae infection,0.005180691162792406,20.232723577235774,106.48111760263689,KCNQ1;PLCG2,0.020124992593924345,KEGG_2021_Human,PLCG2,KCNQ1,,1,1,0
35,Interleukin-12/STAT4 pathway,0.004215395129783775,22.59103800340329,123.55065676287644,HLA-DRA;HLA-DRB1,0.024121427687096048,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
36,Wnt interactions in lipid metabolism and immune response,0.004215395129783775,22.59103800340329,123.55065676287644,PLCG2;APOE,0.024121427687096048,BioPlanet_2019,PLCG2;APOE,,,2,0,0
17,Nuclear Signaling By ERBB4 R-HSA-1251985,0.0021496497140763666,32.40162601626016,199.02537983535302,APH1B;APOE,0.024531296737106772,Reactome_2022,APH1B;APOE,,,2,0,0
37,Chondroitin sulfate/dermatan sulfate metabolism,0.004783448141947699,21.114528101802758,112.80634320901902,IDUA;CHST15,0.026632170736249353,BioPlanet_2019,IDUA,CHST15,,1,1,0
38,Interleukin-5 signaling pathway,0.004980226270684628,20.664244940321744,109.56761169296043,HLA-DRA;HLA-DRB1,0.026998068730553514,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
18,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.002715571355744258,28.58393113342898,168.89538608185973,CDKN1C;CCND2,0.029267824611910336,Reactome_2022,,CDKN1C;CCND2,,0,2,0
19,Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN1C;CCND2,0.03085616167216906,Reactome_2022,,CDKN1C;CCND2,,0,2,0
39,Vibrio cholerae infection,0.006237758643052818,18.319374137137597,93.00992375609684,KCNQ1;PLCG2,0.032948161037663605,BioPlanet_2019,PLCG2,KCNQ1,,1,1,0
20,DAP12 Interactions R-HSA-2172127,0.0038554225788541055,23.695419393218323,131.70564916179435,PLCG2;TREM2,0.03576574415572211,Reactome_2022,PLCG2;TREM2,,,2,0,0
21,Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.0038715496251039406,10.319270833333333,57.31426659503001,CDKN1C;CDKN2B;CCND2,0.03576574415572211,Reactome_2022,,CDKN1C;CDKN2B;CCND2,,0,3,0
40,Interleukin-12-mediated signaling events,0.00861930890913937,15.40379403794038,73.22579161456777,HLA-DRA;HLA-DRB1,0.04438944088206776,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
22,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.005180691162792406,20.232723577235774,106.48111760263689,IDUA;CHST15,0.045684276617351215,Reactome_2022,IDUA,CHST15,,1,1,0
41,T cell receptor signaling in naive CD4+ T cells,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRA;HLA-DRB1,0.04590960795228703,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
